Theravance Biopharma (TBPH) Stock Chart & Stock Price History $8.53 +0.21 (+2.52%) Closing price 04/9/2025 04:00 PM EasternExtended Trading$8.53 0.00 (0.00%) As of 04/9/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Theravance Biopharma Stock Price Performance 5 Day Performance+1.07%1 Month Performance-9.83%3 Month Performance-2.85%6 Month Performance+5.83%Year-To-Date Performance-9.35%1 Year Performance-10.59% Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address TBPH Stock Chart for Thursday, April, 10, 2025 TBPH Chart by TradingViewRemove Ads Theravance Biopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/09/2025$8.32$8.53+2.52%$8.81$8.09375,245 shs$421.99 million04/09/2025$8.32$8.53+2.52%$8.81$8.09375,245 shs$421.99 million04/08/2025$8.41$8.32-1.07%$9.16$8.23274,794 shs$411.60 million04/08/2025$8.41$8.32-1.07%$9.16$8.23274,794 shs$411.60 million04/07/2025$8.44$8.41-0.36%$8.66$7.90275,529 shs$416.05 million04/04/2025$8.77$8.44-3.76%$8.64$8.33218,939 shs$417.54 million04/03/2025$9.01$8.77-2.66%$9.08$8.65213,671 shs$433.86 million04/02/2025$9.02$9.01-0.11%$9.20$8.77236,352 shs$445.73 million04/01/2025$8.93$9.02+1.01%$9.09$8.72255,205 shs$446.23 million03/31/2025$9.23$8.93-3.25%$9.15$8.93376,303 shs$441.78 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 03/28/2025$9.31$9.23-0.86%$9.42$9.18135,276 shs$456.62 million03/27/2025$9.30$9.31+0.11%$9.42$9.05220,463 shs$460.58 million03/26/2025$9.31$9.30-0.11%$9.39$9.29157,314 shs$460.08 million03/25/2025$9.39$9.31-0.85%$9.44$9.30143,369 shs$460.58 million03/24/2025$9.39$9.39$9.50$9.34130,916 shs$464.53 million03/21/2025$9.36$9.39+0.32%$9.55$9.32268,235 shs$464.53 million03/20/2025$9.47$9.36-1.16%$9.51$9.2793,470 shs$463.05 million03/19/2025$9.21$9.47+2.82%$9.50$9.19100,307 shs$468.49 million03/18/2025$9.35$9.21-1.50%$9.50$9.21179,728 shs$455.63 million03/17/2025$9.23$9.35+1.30%$9.44$9.24167,372 shs$462.55 million03/14/2025$9.28$9.23-0.54%$9.40$9.23337,410 shs$456.62 million03/13/2025$9.44$9.28-1.69%$9.39$9.06184,426 shs$459.09 million03/12/2025$9.29$9.44+1.61%$9.52$9.16171,253 shs$464.20 million03/11/2025$9.46$9.29-1.80%$9.47$9.12234,294 shs$456.83 million03/10/2025$9.53$9.46-0.73%$9.70$9.37148,767 shs$465.19 million Related Companies HRMY Stock Price Chart DVAX Stock Price Chart GLPG Stock Price Chart CNTA Stock Price Chart AGIO Stock Price Chart KNSA Stock Price Chart ANIP Stock Price Chart JANX Stock Price Chart MNKD Stock Price Chart ARWR Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersThe Most Bullish Metric For Stocks (NOT Volume…)Before placing a single trade, Tim Sykes always checks one key bullish metric. It’s the same signal that has s...MillPub | SponsoredTrump’s policies mean HUGE income for investorsThanks to a Trump win… Investors have a HUGE opportunity at new income. The floodgates for U.S. oil prod...The Oxford Club | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWhy crypto may be the best way to play this chaotic market …Wall Street is in chaos … Over $6 trillion was wiped … in just two days. But something else was happenin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theravance Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TBPH Stock Free TBPH Stock Alerts